Literature DB >> 15084518

Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow.

Lin Song1, Rocky S Tuan.   

Abstract

Transdifferentiation is a process whereby one cell type committed to and progressing along a specific developmental lineage switches into another cell type of a different lineage through genetic reprogramming. Even though this process has been well studied and established in amphibian systems, it is unclear if mammalian cells possess the same potential. Recent in vivo transplantation studies showed that adult mesenchymal stem cells (MSCs) were able to differentiate into mesoderm-derived cell types as well as cells with neuroectodermal and endodermal characteristics, suggesting that transdifferentiation occurs in mammalian systems. However, there are concerns over these findings because of the possibility of progenitor cell contamination and cell fusion. In this study, we have developed an in vitro differentiation strategy to assess if human MSCs that have differentiated into a given mesenchyme cell lineage can transdifferentiate into other cell types in response to inductive extracellular cues. Our results showed that fully differentiated cells from hMSCs were capable of dedifferentiation and transdifferentiation into cells of another developmental lineage at single cell levels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15084518     DOI: 10.1096/fj.03-1100fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  131 in total

1.  Short-term physical activity intervention decreases femoral bone marrow adipose tissue in young children: a pilot study.

Authors:  K Casazza; L J Hanks; B Hidalgo; H H Hu; O Affuso
Journal:  Bone       Date:  2011-09-13       Impact factor: 4.398

2.  Identification of a restriction point at the M/G1 transition in CHO cells.

Authors:  E Hullemann; J J M Bijvelt; A J Verkleij; C T Verrips; J Boonstra
Journal:  Cell Mol Life Sci       Date:  2004-03       Impact factor: 9.261

Review 3.  Regeneration of the vascular compartment.

Authors:  M U Becher; G Nickenig; N Werner
Journal:  Herz       Date:  2010-08       Impact factor: 1.443

Review 4.  Bone marrow mesenchymal stem cells: historical overview and concepts.

Authors:  Pierre Charbord
Journal:  Hum Gene Ther       Date:  2010-09       Impact factor: 5.695

Review 5.  The obesity of bone.

Authors:  Emanuela A Greco; Andrea Lenzi; Silvia Migliaccio
Journal:  Ther Adv Endocrinol Metab       Date:  2015-12       Impact factor: 3.565

Review 6.  Anti-fibrogenic strategies and the regression of fibrosis.

Authors:  Tatiana Kisseleva; David A Brenner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-04       Impact factor: 3.043

Review 7.  Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells.

Authors:  D Garbossa; M Boido; M Fontanella; C Fronda; A Ducati; A Vercelli
Journal:  Neurosurg Rev       Date:  2012-04-27       Impact factor: 3.042

8.  Human bone marrow-derived mesenchymal stem cells display enhanced clonogenicity but impaired differentiation with hypoxic preconditioning.

Authors:  Lisa B Boyette; Olivia A Creasey; Lynda Guzik; Thomas Lozito; Rocky S Tuan
Journal:  Stem Cells Transl Med       Date:  2014-01-16       Impact factor: 6.940

9.  Fat tissue, a potential Schwann cell reservoir: isolation and identification of adipose-derived Schwann cells.

Authors:  Lulu Chen; Yuqing Jin; Xiaonan Yang; Zhangyin Liu; Yang Wang; Gangyang Wang; Zuoliang Qi; Zunli Shen
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

10.  The immunomodulatory properties of human bone marrow-derived mesenchymal stromal cells are defined according to multiple immunobiological criteria.

Authors:  Hussein Fayyad-Kazan; Wissam H Faour; Bassam Badran; Laurence Lagneaux; Mehdi Najar
Journal:  Inflamm Res       Date:  2016-03-08       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.